First human tests begin for potential new lupus treatment

NCT ID NCT06013995

Recruiting now Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

Summary

This is an early safety study for a new drug called BMS-986326 for people with different types of lupus. The main goal is to see if the drug is safe and how the body processes it when given in increasing doses. Researchers will also check if the drug affects certain immune cells that may play a role in lupus.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Allen Arthritis
WITHDRAWN

Allen, Texas, 75013, United States
Arthritis Northwest, PLLC
RECRUITING

Spokane, Washington, 99204, United States

Contact Phone: •••-•••-••••
Clinica Adventista Belgrano
RECRUITING

CABA, Buenos Aires F.D., 1430, Argentina

Contact Phone: •••-•••-••••
Clinical Research of West Florida
RECRUITING

Tampa, Florida, 33606, United States

Contact Phone: •••-•••-••••
Clinical Research of West Florida, Inc. (Clearwater)
RECRUITING

Clearwater, Florida, 33765, United States

Contact Phone: •••-•••-••••
Columbia University Irving Medical Center
WITHDRAWN

New York, New York, 10032, United States
Hospital Universitario Austral
RECRUITING

Pilar, Buenos Aires, 1629, Argentina

Contact Phone: •••-•••-••••
Local Institution - 0005
COMPLETED

Duncansville, Pennsylvania, 16635, United States
Local Institution - 0044
COMPLETED

Berlin, 10117, Germany
Local Institution - 0045
COMPLETED

Córdoba, Córdoba, 14004, Spain
Local Institution - 0046
COMPLETED

A Coruña, A Coruña [La Coruña], 15006, Spain
Local Institution - 0047
COMPLETED

Dresden, 01307, Germany
Local Institution - 0048
COMPLETED

San Diego, California, 92108, United States
Local Institution - 0051
COMPLETED

Leiden, 2333 CL, Netherlands
Local Institution - 0062
COMPLETED

Las Vegas, Nevada, 89102, United States
Local Institution - 0064
ACTIVE_NOT_RECRUITING

Cluj-Napoca, Cluj, 400006, Romania
Local Institution - 0065
ACTIVE_NOT_RECRUITING

Bucharest, București, 11658, Romania
Local Institution - 0068
WITHDRAWN

Mexico City, DIF, 07760, Mexico
Local Institution - 0069
ACTIVE_NOT_RECRUITING

Warsaw, 02-953, Poland
Local Institution - 0071
ACTIVE_NOT_RECRUITING

Dessau, 06847, Germany
Local Institution - 0072
ACTIVE_NOT_RECRUITING

Sofia, 1618, Bulgaria
Local Institution - 0073
WITHDRAWN

Cuauhtémoc, Ciudad de México, DIF, 06100, Mexico
Local Institution - 0074
ACTIVE_NOT_RECRUITING

Poznan, 61-848, Poland
Local Institution - 0077
WITHDRAWN

Chihuahua City, 31217, Mexico
Metroplex Clinical Research Center
WITHDRAWN

Dallas, Texas, 75231, United States
North Georgia Rheumatology
WITHDRAWN

Lawrenceville, Georgia, 30046, United States
Skin Sciences
RECRUITING

Louisville, Kentucky, 40217, United States

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

LUPUS